Plasma Levels of Fatty Acid–Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study. Issue 11 (November 2016)
- Record Type:
- Journal Article
- Title:
- Plasma Levels of Fatty Acid–Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study. Issue 11 (November 2016)
- Main Title:
- Plasma Levels of Fatty Acid–Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes
- Authors:
- Liu, Gang
Ding, Ming
Chiuve, Stephanie E.
Rimm, Eric B.
Franks, Paul W.
Meigs, James B.
Hu, Frank B.
Sun, Qi - Abstract:
- Abstract : Objective—: To examine select adipokines, including fatty acid–binding protein 4, retinol-binding protein 4, and high-molecular-weight (HMW) adiponectin in relation to cardiovascular disease (CVD) mortality among patients with type 2 diabetes mellitus. Approach and Results—: Plasma levels of fatty acid–binding protein 4, retinol-binding protein 4, and HMW adiponectin were measured in 950 men with type 2 diabetes mellitus in the Health Professionals Follow-up Study. After an average of 22 years of follow-up (1993–2015), 580 deaths occurred, of whom 220 died of CVD. After multivariate adjustment for covariates, higher levels of fatty acid–binding protein 4 were significantly associated with a higher CVD mortality: comparing extreme tertiles, the hazard ratio and 95% confidence interval of CVD mortality was 1.78 (1.22–2.59; P trend=0.001). A positive association was also observed for HMW adiponectin: the hazard ratio (95% confidence interval) was 2.07 (1.42–3.06; P trend=0.0002), comparing extreme tertiles, whereas higher retinol-binding protein 4 levels were nonsignificantly associated with a decreased CVD mortality with an hazard ratio (95% confidence interval) of 0.73 (0.50–1.07; P trend=0.09). A Mendelian randomization analysis suggested that the causal relationships of HMW adiponectin and retinol-binding protein 4 would be directionally opposite to those observed based on the biomarkers, although none of the Mendelian randomization associations achievedAbstract : Objective—: To examine select adipokines, including fatty acid–binding protein 4, retinol-binding protein 4, and high-molecular-weight (HMW) adiponectin in relation to cardiovascular disease (CVD) mortality among patients with type 2 diabetes mellitus. Approach and Results—: Plasma levels of fatty acid–binding protein 4, retinol-binding protein 4, and HMW adiponectin were measured in 950 men with type 2 diabetes mellitus in the Health Professionals Follow-up Study. After an average of 22 years of follow-up (1993–2015), 580 deaths occurred, of whom 220 died of CVD. After multivariate adjustment for covariates, higher levels of fatty acid–binding protein 4 were significantly associated with a higher CVD mortality: comparing extreme tertiles, the hazard ratio and 95% confidence interval of CVD mortality was 1.78 (1.22–2.59; P trend=0.001). A positive association was also observed for HMW adiponectin: the hazard ratio (95% confidence interval) was 2.07 (1.42–3.06; P trend=0.0002), comparing extreme tertiles, whereas higher retinol-binding protein 4 levels were nonsignificantly associated with a decreased CVD mortality with an hazard ratio (95% confidence interval) of 0.73 (0.50–1.07; P trend=0.09). A Mendelian randomization analysis suggested that the causal relationships of HMW adiponectin and retinol-binding protein 4 would be directionally opposite to those observed based on the biomarkers, although none of the Mendelian randomization associations achieved statistical significance. Conclusions—: These data suggest that higher levels of fatty acid–binding protein 4 and HMW adiponectin are associated with elevated CVD mortality among men with type 2 diabetes mellitus. Biological mechanisms underlying these observations deserve elucidation, but the associations of HMW adiponectin may partially reflect altered adipose tissue functionality among patients with type 2 diabetes mellitus. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- Arteriosclerosis, thrombosis, and vascular biology. Volume 36:Issue 11(2016)
- Journal:
- Arteriosclerosis, thrombosis, and vascular biology
- Issue:
- Volume 36:Issue 11(2016)
- Issue Display:
- Volume 36, Issue 11 (2016)
- Year:
- 2016
- Volume:
- 36
- Issue:
- 11
- Issue Sort Value:
- 2016-0036-0011-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-11
- Subjects:
- adipokines -- adiponectin -- cardiovascular disease -- fatty acid–binding proteins -- heart failure
Arteriosclerosis -- Periodicals
Thrombosis -- Periodicals
Blood-vessels -- Pathophysiology -- Periodicals
Electronic journals
616.13 - Journal URLs:
- http://atvb.ahajournals.org/contents-by-date.0.shtml ↗
http://journals.lww.com ↗ - DOI:
- 10.1161/ATVBAHA.116.308320 ↗
- Languages:
- English
- ISSNs:
- 1079-5642
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1733.670000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 1469.xml